Stock market news: Denmark-based pharmaceutical giant, Novo Nordisk, stock price jumped more than 7% during the stock market session on Tuesday, 23 December 2025, after the company’s weight loss drug Wegovy pill received the US Food and Drug Administration (FDA) approval on 22 December 2025.
Novo Nordisk shares jumped more than 7% during the trading session at Denmark today, while the Novo Nordisk ADR shares listed on the New York Stock Exchange (NYSE) jumped over 10% during Monday’s after-market hours trading session, according to MarketWatch data.
(This is a developing story. Please check back for updates.)
Read all stories by Anubhav Mukherjee
Disclaimer: This story is for educational purposes only. We advise investors to check with certified experts before making any investment decisions.
